A formal definition and a new security mechanism of physical unclonable functions

The characteristic novelty of what is generally meant by a "physical unclonable function" (PUF) is precisely defined, in order to supply a firm basis for security evaluations and the proposal of new security mechanisms. A PUF is defined as a hardware device which implements a physical function with an output value that changes with its argument. A PUF can be clonable, but a secure PUF must be unclonable. This proposed meaning of a PUF is cleanly delineated from the closely related concepts of "conventional unclonable function", "physically obfuscated key", "random-number generator", "controlled PUF" and "strong PUF". The structure of a systematic security evaluation of a PUF enabled by the proposed formal definition is outlined. Practically all current and novel physical (but not conventional) unclonable physical functions are PUFs by our definition. Thereby the proposed definition captures the existing intuition about what is a PUF and remains flexible enough to encompass further research. In a second part we quantitatively characterize two classes of PUF security mechanisms, the standard one, based on a minimum secret read-out time, and a novel one, based on challenge-dependent erasure of stored information. The new mechanism is shown to allow in principle the construction of a "quantum-PUF", that is absolutely secure while not requiring the storage of an exponentially large secret. The construction of a PUF that is mathematically and physically unclonable in principle does not contradict the laws of physics.Comment: 13 pages, 1 figure, Conference Proceedings MMB & DFT 2012, Kaiserslautern, German

The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation

Background: This review examines the clinical effectiveness and cost-effectiveness of hand-held inhalers to deliver medication for the routine management of chronic asthma in children aged between 5 and 15 years. Asthma is a common disease of the airways, with a prevalence of treated asthma in 5–15-year-olds of around 12% and an actual prevalence in the community as high as 23%. Treatment for the condition is predominantly by inhalation of medication. There are three main types of inhaler device, pressurised metered dose, breath actuated, and dry powder, with the option of the attachment of a spacer to the first two devices under some prescribed circumstances. Two recent reviews have examined the clinical and cost-effectiveness evidence on inhaler devices, but one was for children aged under 5 years and the comparison in the second was made between pressurised metered dose inhalers and other types only. Objectives: This review examines the clinical effectiveness and cost-effectiveness of manual pressurised metered dose inhalers, breath-actuated metered dose inhalers, and breath-actuated dry powder inhalers, with and without spacers as appropriate, to deliver medication for the routine management of chronic asthma in children aged between 5 and 15 years. Methods: Two previous HTA reviews have compared the effectiveness of inhaler devices, one focusing on asthma in children aged under 5 years and the other on asthma and chronic obstructive airways disease in all age groups. For the current review, a literature search was carried out to identify all evidence relating to the use of inhalers in older children with chronic asthma. A search of in-vitro studies undertaken for one of the previous reviews was also updated. The data sources used were: 15 electronic bibliographic databases; the reference lists of one of the previous HTA reports and other relevant articles; health services research-related internet resources; and all sponsor submissions. Studies were selected according to strict inclusion and exclusion criteria, and relevant information concerning effectiveness and patient compliance and preference was extracted directly on to an extraction/evidence table. Quality assurance was monitored. Economic evaluation was undertaken by reviewing existing cost-effective evidence. Further economic modelling was carried out, and tables constructed to determine device cost-minimisation and incremental quality-adjusted life-year (QALY) thresholds between devices. Results: Number and quality of studies, and direction of evidence: Fourteen randomised controlled studies were identified relating to the clinical effectiveness of inhaler devices for delivering β2-agonists. A further five were on devices delivering corticosteroids and one concerned the delivery of cromoglicate. Overall, there were no differences in clinical efficacy between inhaler devices, but a pressurised metered dose inhaler with a spacer would appear to be more effective than one without. These findings endorse those of a previous HTA review but extend them to other inhaler devices. Seven randomised controlled trials examined the impact on clinical effectiveness of using a nonchlorofluorocarbon (CFC) propellant in place of a CFC propellant in metered dose inhalers, both pressurised and breath activated, although only one study considered the latter type. No differences were found between inhalers containing either propellant. A further 30 studies of varying quality, from 12 randomised controlled trials to non-controlled studies, were identified that concerned the impact of use by, and preference for, inhaler type, and treatment adherence in children. Differences between the studies, and limitations in comparative data between various inhaler device types, make it difficult to draw any firm conclusions from this evidence. Summary of benefits: No obvious benefits for one inhaler device type over another for use in children aged 5–15 years were identified. Costs and cost per quality-adjusted life-year: Two approaches have been taken: cost-minimisation and QALY threshold. In the QALY threshold approach, additional QALYs that each device must produce compared with a cheaper device to achieve an acceptable cost per QALY were calculated. Using the cheapest and most expensive devices for delivering 200 μg of beclometasone per day, assuming no cost offset for any device, and a threshold of £5000, the largest QALY needed was 0.00807. With such a small QALY increase, no intervention can be categorically rejected as not cost-effective. Conclusions: Generalisability of findings: On the available evidence there are no obvious benefits for one inhaler device over another when used by children aged 5–15 years with chronic asthma. However, the evidence, in the majority of cases, was compiled on children with mild to moderate asthma and restricted to a limited number of drugs. Therefore the findings may not be generalisable to those at the more severe end of the spectrum of the disease or to inhaler devices delivering some of the drugs used in the management of asthma. Need for further research: Many of the previous studies are likely to have been underpowered. Further clinical trials with a robust methodology, sufficient power and qualitative components are needed to demonstrate any differences in clinical resource use and patients’ asthma symptoms. Further studies should also include the behavioural aspects of patients towards their medication and its delivery mechanisms. It is acknowledged that sufficient power may prove impractical owing to the large numbers of patients required

Making information accessible for the conservation and use of biodiversity. A novel initiative to facilitate access to information and use of agricultural and tree biodiversity

Poster presented at Science Week 2014 - Bioversity International HQ, Rome (Italy), 24-27 Feb 201

Optical studies of carrier and phonon dynamics in Ga_{1-x}Mn_{x}As

We present a time-resolved optical study of the dynamics of carriers and phonons in Ga_{1-x}Mn_{x}As layers for a series of Mn and hole concentrations. While band filling is the dominant effect in transient optical absorption in low-temperature-grown (LT) GaAs, band gap renormalization effects become important with increasing Mn concentration in Ga_{1-x}Mn_{x}As, as inferred from the sign of the absorption change. We also report direct observation on lattice vibrations in Ga1-xMnxAs layers via reflective electro-optic sampling technique. The data show increasingly fast dephasing of LO phonon oscillations for samples with increasing Mn and hole concentration, which can be understood in term of phonon scattering by the holes.Comment: 13 pages, 3 figures replaced Fig.1 after finding a mistake in previous versio

Supersymmetry in gauge theories with extra dimensions

We show that a quantum-mechanical N=2 supersymmetry is hidden in 4d mass spectrum of any gauge invariant theories with extra dimensions. The N=2 supercharges are explicitly constructed in terms of differential forms. The analysis can be extended to extra dimensions with boundaries, and for a single extra dimension we clarify a possible set of boundary conditions consistent with 5d gauge invariance, although some of the boundary conditions break 4d gauge symmetries.Comment: 18 page

Cotunneling drag effect in Coulomb-coupled quantum dots

In Coulomb drag, a current flowing in one conductor can induce a voltage across an adjacent conductor via the Coulomb interaction. The mechanisms yielding drag effects are not always understood, even though drag effects are sufficiently general to be seen in many low-dimensional systems. In this Letter, we observe Coulomb drag in a Coulomb-coupled double quantum dot (CC-DQD) and, through both experimental and theoretical arguments, identify cotunneling as essential to obtaining a correct qualitative understanding of the drag behavior.Comment: Main text: 5 pages, 5 figures; SM: 11 pages, 5 figures, 1 tabl

Design zero-voltage switching DC-DC buck converter

This report proposes an integrated, high switching frequency, zero-voltage-switching dc-dc buck converter for battery charger application. The design and analysis of dc�dc buck converter with integrated inductor is presented. The converter has been optimized to convert 12V input voltage to 5V at 1.5A maximum load current at 50MHz switching frequency. The converter has been simulated using an ORCAD 16.5 based simulation tool and result show that the switching losses using zero�voltage-switching technique is less compared to conventional buck converter